Full-dose blood thinners decreased need for life support and improved COVID outcomes
Tumor cells reveal a core syncytial drive to evade host defenses
25 January 2021Smoking killing one in three First Nations people
25 January 2021Full-dose blood thinners decreased need for life support and improved COVID outcomes
Full-dose anti-coagulation (blood thinner) treatments given to patients hospitalized for COVID-19 reduced the requirement of vital organ support in a large clinical trial conducted worldwide. With large numbers of COVID-19 patients requiring hospitalization, this treatment is expected to reduce the pressure in intensive care units around the world.
